A MolEcularly Guided Anti-Cancer Drug Off-Label Trial

NCT04185831 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

167

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Atezolizumab
DRUG: Everolimus
DRUG: Cobimetinib
DRUG: Niraparib

Sponsor

Uppsala University Hospital